Pragtis s.r.o.
- Address
- Vinohradska 208/14, Vinohrady, 120 00 Prague, Czechia
Pragtis s.r.o. - Psychiatric Research Center
Pragtis s.r.o. is a specialized clinical research facility focused on advancing treatments for severe psychiatric conditions. The center demonstrates significant expertise in conducting complex psychiatric trials, with particular emphasis on cognitive impairment and mood disorders. Their research portfolio reflects a commitment to evaluating both the efficacy and long-term safety profiles of novel therapeutic agents in challenging psychiatric populations.
- Schizophrenia and cognitive impairment assessment, including long-term safety extension studies
- Major Depressive Disorder with moderate-to-severe anhedonia and treatment-resistant depression
- Adjunctive therapy evaluation and relapse prevention strategies in psychiatric disorders
The center has established robust capabilities in managing randomized, double-blind, placebo-controlled trials and extended open-label studies. Their involvement in multi-phase clinical trial programs, including Phase III studies and long-term extension protocols, demonstrates their capacity to support comprehensive drug development programs. Pragtis s.r.o. specializes in evaluating novel pharmacological approaches, including kappa opioid receptor antagonists and other innovative mechanisms, particularly in patients with inadequate response to standard antidepressant therapy.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Janssen Cilag International1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Janssen Cilag International3trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Pragtis s.r.o.
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Adjunctive Aticaprant and Antidepressant Therapy for Relapse Prevention in Major Depressive Disorder with Moderate-to-Severe Anhedonia: A Randomized, Double-Blind Study | Janssen Cilag International | Phase III | Not Recruiting | Dec 2024 | Feb 2025 |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Aticaprant | 2 | Unknown | 2024-11-14 | 2024-12-04 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.